Impacts of off-label dosing noacs on clinical outcomes in very elderly patients with atrial fibrillation

被引：0
|
作者：
Chao, T. [1 ]
Chan, Y. H. [2 ]
Lip, G. Y. H. [3 ]
Chen, S. A. [4 ]
机构：
[1] Taipei Vet Gen Hosp, Taipei, Taiwan
[2] Chang Gung Mem Hosp, Taoyuan, Taiwan
[3] Univ Liverpool, Liverpool, Merseyside, England
[4] Taichung Vet Gen Hosp, Taichung, Taiwan
来源：
EUROPEAN HEART JOURNAL | 2021年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：565 / 565
页数：1
相关论文
共 50 条
  • [41] Safety and Efficacy Re-Evaluation of Edoxaban and Rivaroxaban Dosing With Plasma Concentration Monitoring in Non-Valvular Atrial Fibrillation: With Observations of On-Label and Off-Label Dosing
    Suwa, Michihiro
    Nohara, Yuki
    Morii, Isao
    Kino, Masaya
    CIRCULATION REPORTS, 2023, 5 (03) : 80 - 89
  • [42] Pattern and Impact of Off-label Underdosing of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Who are Indicated for Standard Dosing
    Cho, Min Soo
    Yun, Ji Eun
    Park, Ji Jeong
    Kim, Yun Jung
    Lee, Jessie
    Kim, Hyungmin
    Park, Duk-Woo
    Nam, Gi-Byoung
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 125 (09): : 1332 - 1338
  • [43] Clinical profile and outcomes in very elderly patients with atrial fibrillation anticoagulated with rivaroxaban:data from the EMIR study
    Francisco Marn
    Manuel Anguita Snchez
    Iaki Lekuona
    Marcelo Sanmartn Fernndez
    Vivencio Barrios
    Carlos Perez Muoz
    Juan CosnSales
    Alejandro IPrez Cabeza
    Vanesa Roldn Schilling
    Carles Rafols Priu
    Esteban OrenesPiero
    Mara Asuncin EstevePastor
    Journal of Geriatric Cardiology, 2024, 21 (07) : 723 - 732
  • [44] SAFETY AND OUTCOMES OF CATHETER ABLATION FOR ATRIAL FIBRILLATION IN THE VERY ELDERLY
    Salerno, Colby
    Sawalha, Khalid
    Motta, Jishu
    Abozenah, Mohammed
    Pundlik, Shayal
    Abdelazeem, Mohamed
    Farah, Michel
    Kadado, Anis John
    Chalhoub, Fadi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 14 - 14
  • [45] Off-label prescriptions of levomepromazine for sleep disturbances in elderly patients
    Arts, M.
    Petrykiv, S.
    Fennema, J.
    de Jonge, L.
    EUROPEAN PSYCHIATRY, 2018, 48 : S179 - S180
  • [46] Off-label prescription of tigecycline: clinical and microbiological characteristics and outcomes
    Conde-Estevez, David
    Grau, Santiago
    Pablo Horcajada, Juan
    Luque, Sonia
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 36 (05) : 471 - 472
  • [47] Rivaroxaban or Apixaban or Non-Valvular Atrial Fibrillation - Efficacy and Safety of Off-Label Under-Dosing According to Plasma Concentration
    Suwa, Michihiro
    Morii, Isao
    Kino, Masaya
    CIRCULATION JOURNAL, 2019, 83 (05) : 991 - +
  • [48] Off-Label Under- and Overdosing of Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Meta-Analysis
    Zhang, Xin-Lin
    Zhang, Xiao-Wen
    Wang, Ting-Yu
    Wang, Hong-Wei
    Chen, Zheng
    Xu, Biao
    Xu, Wei
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2021, 14 (12): : 1224 - 1237
  • [49] Representation of African-American Patients in Clinical Trials of NOACs in Atrial Fibrillation
    Oren, Ohad
    Oren, Michal
    CIRCULATION, 2017, 136
  • [50] Inappropriate dosing of non-vitamin K oral anticoagulants (NOACs) in atrial fibrillation patients in Europe
    Palau, I.
    Heinz, S.
    Cheng, B. Y.
    Brown, S.
    EUROPEAN HEART JOURNAL, 2019, 40 : 2947 - 2947
12345